Trials / Completed
CompletedNCT03048526
Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Novaliq GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with mild to moderate dry eye disease will be randomized to receive either NovaTears® or Hydrabak® eye drops as control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovaTears® | Topical eye drops for lubrication of the ocular surface |
| DEVICE | Hydrabak® | Eye drops |
Timeline
- Start date
- 2016-12-15
- Primary completion
- 2017-04-18
- Completion
- 2017-04-18
- First posted
- 2017-02-09
- Last updated
- 2017-07-05
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03048526. Inclusion in this directory is not an endorsement.